Worksport Ltd. Announces New Distribution Partnership with Dix Performance North to Expand Presence Across Canada
West Seneca, New York, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq: WKSP) (“Worksport” or the “Company”) is proud...
Month: February 2024
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
Contacts Carly Scaduto Senior Director, Media Relations cscaduto@vir.bio +1-314-368-5189 Investors Richard Lepke Senior Director, Investor Relations rlepke@vir.bio +1 978-973-9986 Vir...
Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Wavelo signs three new customers on the heels of 2023 revenue of $38.7 million
Modern software provider automating billing and provisioning for telecommunications customers worldwide TORONTO, Feb. 23, 2024 /PRNewswire/ - Today Wavelo—a modern software company...
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
Contacts Inquiries: Silence Therapeutics plc Gem Hopkins, Head of IR and Corporate Communications ir@silence-therapeutics.com Tel: +1 (646) 637-3208 Silence Therapeutics...
Comscore to Announce Fourth Quarter 2023 Financial Results
RESTON, Va., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating...
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
SIOUX FALLS, S.D., Feb. 23, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical...
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
SIOUX FALLS, S.D., Feb. 23, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical...
Ribbon Named to Newsweek’s Greatest Workplaces for Women 2024
Recognizes Ribbon's commitment to creating a workplace where women can thrive PLANO, Texas, Feb. 23, 2024 /PRNewswire/ -- Ribbon Communications...
QCR Holdings, Inc. Announces a Cash Dividend of $0.06 Per Share
MOLINE, Ill., Feb. 23, 2024 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) today announced that on February 21, 2023,...
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
FARMINGTON HILLS, Mich., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage ophthalmic biopharmaceutical company...
Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on...
Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and...
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
Contacts Investor/Media Contact: Raj Denhoy 415-828-1044 rdenhoy@establishmentlabs.com Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to...
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
Enveric continues focused investment advancing novel neuroplastogenic molecules for the treatment of mental health disorders Contacts Investor Relations Tiberend Strategic...
Criteo Comments on Letter from Petrus Advisers
NEW YORK, Feb. 23, 2024 /PRNewswire/ -- Criteo S.A. (NASDAQ: CRTO) ("Criteo" or the "Company"), the commerce media company, today...
Alkami to Present at Citizens JMP Technology Conference
PLANO, Texas, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions...
Clearmind Medicine Receives MHI Green Light for its Phase I/IIa Clinical Trial
DENVER, Colo., Feb 23, 2024 (247marketnews.com)- Clearmind Medicine Inc. (NASDAQ:CMND) stated, this morning, that it received approval from the Ministry...
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
ZÜRICH, SWITZERLAND / ACCESSWIRE / February 23, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
ZÜRICH, SWITZERLAND / ACCESSWIRE / February 23, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will...
Scripps reports Q4 2023 financial results
CINCINNATI, Feb. 23, 2024 /PRNewswire/ -- The E.W. Scripps Company (NASDAQ: SSP) delivered $616 million in revenue for the fourth...
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
– Apraglutide nutritional data from STARS Nutrition Phase 2 study in adult patients who have short bowel syndrome with intestinal...
SU Group Reports Selection by a Top 5 Freight Services Company for Enhanced Threat Detection
DENVER, Colo., Feb 23, 2024 (247marketnews.com)- SU Group Holdings Limited (NASDAQ:SUGP) reported, this morning, that is was selected by one...
Calumet Specialty Products Partners, L.P. Reports Fourth Quarter and Full Year 2023 Results
INDIANAPOLIS, Feb. 23, 2024 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the "Partnership," "Calumet," "we," "our" or "us"),...
Popular, Inc. Declares a Cash Dividend of $0.62 per Common Share
Contacts Popular, Inc. Investor Relations: Paul J. Cardillo, 212-417-6721 Senior Vice President and Investor Relations Officer pcardillo@popular.com or Media Relations:...
Brixton Metals Receives Typhoon™ Results and Additional Assays from the Hog Heaven Project, Montana
VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”)...
Cresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg Store
Contacts Media Jason Erkes, Cresco Labs Chief Communications Officer press@crescolabs.com 312-953-2767 Investors investors@crescolabs.com General Cresco Labs Inquiries 312-929-0993 info@crescolabs.com Cresco...
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the...
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
CARVYKTI® is the first CAR-T therapy for patients with relapsed and refractory multiple myeloma to receive a positive CHMP opinion...
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
For the first time, patients with alcohol use disorder will receive the company's unique and proprietary psychedelic - MEAI Vancouver,...
SU Group Suddenly on Fire
DENVER, Colo., Feb 23, 2024 (247marketnews.com)- SU Group Holdings Limited (NASDAQ:SUGP) is suddenly on fire, trading at $5.45, up $2.15...
WARNER BROS. DISCOVERY REPORTS FOURTH-QUARTER AND FULL-YEAR 2023 RESULTS
NEW YORK, Feb. 23, 2024 /PRNewswire/ -- Warner Bros. Discovery, Inc. (the "Company") (Nasdaq: WBD) today reported financial results for...
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the...
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
Contacts Media Inquiries: media@bms.com Investors: investor.relations@bms.com Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the...
Plug and Uline Expand Partnership to Supply Hydrogen and Fuel Cells at Four Additional Sites
LATHAM, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions...
Frontier Reports Fourth-Quarter and Full-Year 2023 Results
Delivered first full year of organic Adjusted EBITDA growth in more than 10 years Guides to accelerated mid-single-digit Adjusted EBITDA...
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
CAMBRIDGE, Mass., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human...
BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world...
Luckin Coffee Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
Fiscal Year 2023 Net Revenues Increased 87%More than 8,000 Net New Store Openings in Fiscal Year 2023; Ended 2023 with...